EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Design of a New Epitope-Based Vaccine against Grass Group 1 Allergens

Dzhemal Moten iD, Tsvetelina Batsalova iD, Desislava Apostolova, Tsvetelina Mladenova, Balik Dzhambazov iD, Ivanka Teneva iD

Advances in Respiratory Medicine · 2023

DOI: 10.3390/arm91060036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2023. Verfasst von Dzhemal Moten und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology, Faculty of Biology, Paisii Hilendarski University of Plovdiv, 24 Tsar Assen Str., 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Seasonal, Hypersensitivity, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, Bulgarian National Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic diseases are a global public health problem that affects up to 30% of the population in industrialized societies. More than 40% of allergic patients suffer from grass pollen allergy. Grass pollen allergens of group 1 and group 5 are the major allergens, since they induce allergic reactions in patients at high rates. In this study, we used immunoinformatic approaches to design an effective epitope-based vaccine against the grass group 1 allergens. After the alignment of all known pollen T-cell and B-cell epitopes from pollen allergens available in the public databases, the epitope GTKSEVEDVIPEGWKADTSY was identified as the most suitable for further analyses. The target sequence was subjected to immunoinformatics analyses to predict antigenic T-cell and B-cell epitopes. Population coverage analysis was performed for CD8+ and CD4+ T-cell epitopes. The selected T-cell epitopes (VEDVIPEGW and TKSEVEDVIPEGWKA) covered 78.87% and 98.20% of the global population and 84.57% and 99.86% of the population of Europe. Selected CD8+, CD4+ T-cell and B-cell epitopes have been validated by molecular docking analysis. CD8+ and CD4+ T-cell epitopes showed a very strong binding affinity to major histocompatibility complex (MHC) class I (MHC I) molecules and MHC class II (MHC II) molecules with global energy scores of −72.1 kcal/mol and −89.59 kcal/mol, respectively. The human IgE-Fc (PDB ID 4J4P) showed a lower affinity with B-cell epitope (ΔG = −34.4 kcal/mol), while the Phl p 2-specific human IgE Fab (PDB ID 2VXQ) had the lowest binding with the B-cell epitope (ΔG = −29.9 kcal/mol). Our immunoinformatics results demonstrated that the peptide GTKSEVEDVIPEGWKADTSY could stimulate the immune system and we performed ex vivo tests showed that the investigated epitope activates T cells isolated from patients with grass pollen allergy, but it is not recognized by IgE antibodies specific for grass pollen allergens. This confirms the importance of such studies to establish universal epitopes to serve as a basis for developing an effective vaccine against a particular group of allergens. Further in vivo studies are needed to validate the effectiveness of such a vaccine against grass pollen allergens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, Allergic, SeasonalHypersensitivityVaccinesHumansAllergensPoaceaeEpitopes, B-LymphocyteEpitopes, T-LymphocyteMolecular Docking SimulationAmino Acid SequencePlant ProteinsImmunoglobulin E

Stichwörter der Autor:innen

epitopesex vivograss allergensimmunoinformaticsimmunotherapyin silicopeptide-based vaccinepollen allergy

Substanzen

AllergensEpitopes, B-LymphocyteEpitopes, T-LymphocytePlant ProteinsImmunoglobulin EVaccines

Autor:innen und Institutionen

  • Department of Developmental Biology, Faculty of Biology, Paisii Hilendarski University of Plovdiv, 24 Tsar Assen Str., 4000 Plovdiv, Bulgaria.
  • Department of Botany and Biological Education, Faculty of Biology, Paisii Hilendarski University of Plovdiv, 24 Tsar Assen Str., 4000 Plovdiv, Bulgaria.

ORCID-Profile: Dzhemal Moten, Tsvetelina Batsalova, Balik Dzhambazov, Ivanka Teneva

Förderung

  • Bulgarian Science Fund
  • Bulgarian National Science Fund

Zitieren

APA

Moten, D., Batsalova, T., Apostolova, D., Mladenova, T., Dzhambazov, B., & Teneva, I. (2023). In Silico Design of a New Epitope-Based Vaccine against Grass Group 1 Allergens. Advances in Respiratory Medicine. https://doi.org/10.3390/arm91060036

Vancouver

Moten D, Batsalova T, Apostolova D, Mladenova T, Dzhambazov B, Teneva I. In Silico Design of a New Epitope-Based Vaccine against Grass Group 1 Allergens. Advances in Respiratory Medicine. 2023. doi:10.3390/arm91060036

BibTeX
@article{Moten2023,
  author = {Moten, Dzhemal and Batsalova, Tsvetelina and Apostolova, Desislava and Mladenova, Tsvetelina and Dzhambazov, Balik and Teneva, Ivanka},
  title = {In Silico Design of a New Epitope-Based Vaccine against Grass Group 1 Allergens},
  journal = {Advances in Respiratory Medicine},
  year = {2023},
  doi = {10.3390/arm91060036}
}
Kostenlos starten →